Literature DB >> 19772483

Chemical analysis of cigarette smoke particulate generated in the MSB-01 in vitro whole smoke exposure system.

Mariano J Scian1, Michael J Oldham, John H Miller, David B Kane, Jeffery S Edmiston, Willie J McKinney.   

Abstract

Cigarette mainstream smoke (MS) is a dynamic aerosol consisting of a gas-vapor phase and a particulate phase. In recent years, novel in vitro whole smoke exposure systems have been developed to expose cells directly to whole MS. One such system is the Burghart Mimic Smoker-01 (MSB-01). Our previous data using the MSB-01 indicated that a 50 +/- 10% loss of particulate matter occurred prior to MS delivery into the exposure chamber. Additionally, a change in aerosol particle diameter was also measured, suggesting that the chemical composition of MS might be changing within the system. In this study, we have expanded on our previous work and compared the particulate phase chemical composition of undiluted and diluted MS generated by the instrument and that of the MS delivered into the exposure chamber. The average percent delivery of cigarette smoke condensate (CSC) detected for all the measured chemical constituents was 35 +/- 13% for undiluted MS and 23 +/- 8% for 1:1 diluted MS. The data also indicate that under our experimental conditions, incomplete mixing of the freshly generated MS occurs during its dilution by the system. Taken together, the data presented here show that significant chemical changes occur between the generation of MS by the system and its delivery into the exposure chamber. This indicates that due to the dynamic nature of cigarette smoke, it is important to characterize the exposure conditions in order to gain the best insight and accurately correlate exposure with biological endpoints.

Mesh:

Substances:

Year:  2009        PMID: 19772483     DOI: 10.1080/08958370802712705

Source DB:  PubMed          Journal:  Inhal Toxicol        ISSN: 0895-8378            Impact factor:   2.724


  8 in total

1.  Monitoring an outdoor smoking area by means of PM2.5 measurement and vegetal biomonitoring.

Authors:  Alan da Silveira Fleck; Maria Fernanda Hornos Carneiro; Fernando Barbosa; Flavia Valladão Thiesen; Sergio Luis Amantea; Claudia Ramos Rhoden
Journal:  Environ Sci Pollut Res Int       Date:  2015-12-11       Impact factor: 4.223

Review 2.  Airway hydration and COPD.

Authors:  Arunava Ghosh; R C Boucher; Robert Tarran
Journal:  Cell Mol Life Sci       Date:  2015-06-12       Impact factor: 9.261

3.  Comparison of real-time instruments and gravimetric method when measuring particulate matter in a residential building.

Authors:  Zuocheng Wang; Leonardo Calderón; Allison P Patton; MaryAnn Sorensen Allacci; Jennifer Senick; Richard Wener; Clinton J Andrews; Gediminas Mainelis
Journal:  J Air Waste Manag Assoc       Date:  2016-11       Impact factor: 2.235

4.  Characterisation of a Vitrocell® VC 10 in vitro smoke exposure system using dose tools and biological analysis.

Authors:  David Thorne; Joanne Kilford; Rebecca Payne; Jason Adamson; Ken Scott; Annette Dalrymple; Clive Meredith; Deborah Dillon
Journal:  Chem Cent J       Date:  2013-09-03       Impact factor: 4.215

5.  Characterization of the Vitrocell® 24/48 in vitro aerosol exposure system using mainstream cigarette smoke.

Authors:  Shoaib Majeed; Stefan Frentzel; Sandra Wagner; Diana Kuehn; Patrice Leroy; Philippe A Guy; Arno Knorr; Julia Hoeng; Manuel C Peitsch
Journal:  Chem Cent J       Date:  2014-11-12       Impact factor: 4.215

6.  Assessment of cigarette smoke particle deposition within the Vitrocell® exposure module using quartz crystal microbalances.

Authors:  Jason Adamson; David Thorne; Annette Dalrymple; Debbie Dillon; Clive Meredith
Journal:  Chem Cent J       Date:  2013-03-12       Impact factor: 4.215

7.  Real-time assessment of cigarette smoke particle deposition in vitro.

Authors:  Jason Adamson; Sophie Hughes; David Azzopardi; John McAughey; Marianna D Gaça
Journal:  Chem Cent J       Date:  2012-09-10       Impact factor: 4.215

Review 8.  Identification of Novel Therapeutic Targets in COPD.

Authors:  Esmaeil Mortaz; Mohammad Reza Masjedi; Peter Barnes
Journal:  Tanaffos       Date:  2011
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.